Mari Yamasue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mari Yamasue has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Kosaku Komiya
Respiratory Medicine and Infectious Diseases, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu 879-5593, Oita, Japan
5 shared publications Hiroshi Mukae
Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan
2 shared publicationsJun-Ichi Kadota
Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan
2 shared publicationsKazufumi Hiramatsu
Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan
2 shared publicationsKazuhiro Yatera
Department of Respiratory Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka, 807- 8556, Japan
2 shared publicationsAkihiro Ito
Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Okayama, Japan
1 shared publication
Latest Publications
- 18 May 2023
- Published by Elsevier in Respiratory Investigation
- Vol. 61 (4) , 487-489
Rebound mortality rate of Legionella pneumonia in Japan
- 18 May 2023
- Published by Elsevier in Respiratory Investigation
- Vol. 61 (4) , 487-489
Rebound mortality rate of Legionella pneumonia in Japan
- Open Access
- 31 January 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis
Which factors are related to false negative results of the interferon-γ release assay (IGRA) is unclear. This systematic review described the risk factors associated with false negative IGRA results. Two authors independently identified studies designed to evaluate risk factors for false negative IGRA results from PubMed, the Cochrane Register of Control Trial database, and EMBASE, accessed on October 22, 2018. Meta-analyses were conducted with random-effect models, and heterogeneity was calculated with the I2 method. Of 1,377 titles and abstracts screened, 47 full texts were selected for review, and we finally included 17 studies in this systematic review. The most commonly studied risk factor (14 studies) was advanced age, followed by low peripheral lymphocyte counts (7 studies), and these factors were associated with false negative results even with different tuberculosis incidences (pooled odds ratio 2.06; 95% CI, 1.68–2.52 in advanced age and 2.68; 95% CI, 2.00–3.61 in low peripheral lymphocyte counts). Advanced age and low peripheral lymphocyte counts may be common risk factors for false negative IGRA results, suggesting that people with these factors need to be carefully followed, even if they have negative IGRA results.
- 31 January 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Open AccessFactors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis
Which factors are related to false negative results of the interferon-γ release assay (IGRA) is unclear. This systematic review described the risk factors associated with false negative IGRA results. Two authors independently identified studies designed to evaluate risk factors for false negative IGRA results from PubMed, the Cochrane Register of Control Trial database, and EMBASE, accessed on October 22, 2018. Meta-analyses were conducted with random-effect models, and heterogeneity was calculated with the I2 method. Of 1,377 titles and abstracts screened, 47 full texts were selected for review, and we finally included 17 studies in this systematic review. The most commonly studied risk factor (14 studies) was advanced age, followed by low peripheral lymphocyte counts (7 studies), and these factors were associated with false negative results even with different tuberculosis incidences (pooled odds ratio 2.06; 95% CI, 1.68–2.52 in advanced age and 2.68; 95% CI, 2.00–3.61 in low peripheral lymphocyte counts). Advanced age and low peripheral lymphocyte counts may be common risk factors for false negative IGRA results, suggesting that people with these factors need to be carefully followed, even if they have negative IGRA results.
- Open Access
- 1 January 2020
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 6 (1)
Increasing mortality rate due to rheumatoid arthritis-related lung diseases in Japan
The rates of death due to RA-LD among deaths from any type of RA-related cause have been increasing in Japan. A large-scale study is required to explain this trend.http://bit.ly/2Ew8fhW
- 1 January 2020
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 6 (1)
Open AccessIncreasing mortality rate due to rheumatoid arthritis-related lung diseases in Japan
The rates of death due to RA-LD among deaths from any type of RA-related cause have been increasing in Japan. A large-scale study is required to explain this trend.http://bit.ly/2Ew8fhW
- 15 August 2019
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 19 (10) , 1006-1009
Effect of long‐term clarithromycin therapy on prevention of pneumonia in older adults: A randomized, controlled trial
Aim: Pneumonia in older adults is increasingly recognized as a healthcare issue in countries with an aging population. Long‐term macrolide therapy reduces exacerbations of chronic respiratory diseases, but its effects on the prevention of pneumonia have not been determined.Methods: We carried out a randomized, controlled trial to test the effect of long‐term clarithromycin therapy on the prevention of pneumonia among older adults. People aged ≥65 years who had recovered from pneumonia within the previous 3 months were recruited and randomly allocated to a long‐term, low‐dose clarithromycin (CAM) therapy group (n = 13) or a control group (n = 15).Results: Both groups were followed up until recurrence of pneumonia. The median follow‐up period was 251 days (95% CI 171–330) in the CAM group and 132 days (95% CI 67–196) in the control group (P = 0.627). The recurrence rate of pneumonia was two out of 13 (15%) in the CAM group and five out of 15 (33%) in the control group (P = 0.268). The median time to recurrence of pneumonia was 315 days (95% CI 249–382) in the CAM group and 260 days (95% CI 184–335) in the control group (P = 0.260). None of the differences between groups were statistically significant.Conclusions: No statistically significant suppressive effects of long‐term, low‐dose macrolide therapy on the development of pneumonia among older people were found in this small sample. A large‐scale, randomized, controlled study is required. Geriatr Gerontol Int 2019; 19: 1006–1009.
- 15 August 2019
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 19 (10) , 1006-1009
Effect of long‐term clarithromycin therapy on prevention of pneumonia in older adults: A randomized, controlled trial
Aim: Pneumonia in older adults is increasingly recognized as a healthcare issue in countries with an aging population. Long‐term macrolide therapy reduces exacerbations of chronic respiratory diseases, but its effects on the prevention of pneumonia have not been determined.Methods: We carried out a randomized, controlled trial to test the effect of long‐term clarithromycin therapy on the prevention of pneumonia among older adults. People aged ≥65 years who had recovered from pneumonia within the previous 3 months were recruited and randomly allocated to a long‐term, low‐dose clarithromycin (CAM) therapy group (n = 13) or a control group (n = 15).Results: Both groups were followed up until recurrence of pneumonia. The median follow‐up period was 251 days (95% CI 171–330) in the CAM group and 132 days (95% CI 67–196) in the control group (P = 0.627). The recurrence rate of pneumonia was two out of 13 (15%) in the CAM group and five out of 15 (33%) in the control group (P = 0.268). The median time to recurrence of pneumonia was 315 days (95% CI 249–382) in the CAM group and 260 days (95% CI 184–335) in the control group (P = 0.260). None of the differences between groups were statistically significant.Conclusions: No statistically significant suppressive effects of long‐term, low‐dose macrolide therapy on the development of pneumonia among older people were found in this small sample. A large‐scale, randomized, controlled study is required. Geriatr Gerontol Int 2019; 19: 1006–1009.
- Open Access
- 1 January 2017
- Vol. 34 (4) , 373-379
INTRASCROTAL AND OSSEOUS SARCOIDOSIS MIMICKING INTRASCROTAL ORGAN CANCER AND BONY METASTASIS
We report a case of sarcoidosis with concomitant epididymis, testes, and phalanxes involvement mimicking intrascrotal organ cancer and metastatic bony disease. A 23-year-old man developed blurred vision and hyperemia of the left eye, and was diagnosed as having left iritis. A chest computed tomography scan detected bilateral hilar lymphadenopathy and lung nodular shadows. A transbronchial lung biopsy revealed a non-caseating granuloma and he was diagnosed with sarcoidosis. One year after the onset of his eye symptoms, he noticed enlargement of his right scrotum. Magnetic resonance imaging detected lesions of the right epididymis, bilateral testes, and bilateral phalanxes. A technetium-99m scintigram revealed a high accumulation in the bilateral bones of extremities. These radiological findings mimicked intrascrotal organ cancer and metastatic bony disease. Pathologic evaluation following the right epididymectomy revealed non-caseating granulomas compatible with sarcoidosis. Three and half years after the appearance of intrascrotal and bony lesions, they improved spontaneously.
- 1 January 2017
- Vol. 34 (4) , 373-379
Open AccessINTRASCROTAL AND OSSEOUS SARCOIDOSIS MIMICKING INTRASCROTAL ORGAN CANCER AND BONY METASTASIS
We report a case of sarcoidosis with concomitant epididymis, testes, and phalanxes involvement mimicking intrascrotal organ cancer and metastatic bony disease. A 23-year-old man developed blurred vision and hyperemia of the left eye, and was diagnosed as having left iritis. A chest computed tomography scan detected bilateral hilar lymphadenopathy and lung nodular shadows. A transbronchial lung biopsy revealed a non-caseating granuloma and he was diagnosed with sarcoidosis. One year after the onset of his eye symptoms, he noticed enlargement of his right scrotum. Magnetic resonance imaging detected lesions of the right epididymis, bilateral testes, and bilateral phalanxes. A technetium-99m scintigram revealed a high accumulation in the bilateral bones of extremities. These radiological findings mimicked intrascrotal organ cancer and metastatic bony disease. Pathologic evaluation following the right epididymectomy revealed non-caseating granulomas compatible with sarcoidosis. Three and half years after the appearance of intrascrotal and bony lesions, they improved spontaneously.